News

Panacea Biotec hits the roof
Capital Market/14:33,Jun 17, 2013
Panacea Biotec was locked in 20% upper circuit at Rs 107.75 at 14:21 IST on BSE, with the stock extending recent gains on follow-up buying.

14:15		Ortin Laboratories reports net loss of Rs 0.78 crore in the March 2013 quarter
14:31		Dr Sabharwal's Manufacturing Labs net profit rises 775.00% in the March 2013 quarter
14:31		Triochem Products net profit rises 4.00% in the March 2013 quarter
16:35		Titan Biotech net profit declines 11.11% in the March 2013 quarter
17:54		Patidar Buildcon reports net profit of Rs 0.02 crore in the March 2013 quarter

Related Research

	Nothing really!
	Vinod Kumar, Managing Director and CEO, Tata Communications
	The Power of Decision
	Rewarding day likely
	Teaching your children about financial matters

Calendar

Jun-2013

M	T	W	T	F	S	S
17	18	19	20	21	22	23

Economic Events

Adjusted Merchandise Trade Balance (Yen)

Merchandise Trade Balance Total (Yen)

View full month Economic Events calendar

Results

No result today

View full month Results calendar

IPO

No IPO today

View full month IPO calendar

Automobiles & Ancillaries

Cap Goods, Eng & Infra

Media & Entertainment

Metals, Mining & Minerals

IndiaInfoline

Markets

News

Corporate News

Print | Email| Font Size

Strides Arcolab's director resigns

Capital Market/ 12:42 , May 28, 2012

With effect from 25 May 2012

Strides Arcolab has announced that Venkat S Iyer, CEO of Agila Specialties and executive director of Strides Arcolab steps down as executive director of Strides with effect from 25 May 2012 to fully focus on the global injectable Agila business.